Wednesday, December 30, 2015

Drugmaker Returns on R&D Are Shrinking Motley Fool-4 hours ago ... but it gives pharmacy-benefit managers ammunition for negotiating hefty discounts ... On its way to becoming the most valuable pharmaceutical asset

Drugmaker Returns on R&D Are Shrinking
Motley Fool-4 hours ago
... but it gives pharmacy-benefit managers ammunition for negotiating hefty discounts ... On its way to becoming the most valuable pharmaceutical asset

No comments: